NCT06341374View on ClinicalTrials.gov

Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

September 30, 2024

Conditions
Apnea, Obstructive SleepSARS CoV 2 Infection
Interventions
BIOLOGICAL

Influvac Tetra

All participants will take influenza vaccine (Influvac Tetra, Abbott Biologicals, IL, USA) and the trained immune response will be evaluated.

Trial Locations (1)

08208

RECRUITING

Hospital Universitari Parc Tauli, Sabadell

All Listed Sponsors
lead

Parc Taulí Hospital Universitari

OTHER